“Our results offer ‘proof of concept’ for the future use of a pharmaceutical senolytic strategy to reduce the risk of IR-induced GI cancer.” “Our results offer ‘proof of concept’ for the future use of ...

Everyone is looking to slow down aging — one class of over-the-counter drugs is growing in popularity because it targets problematic cells. Senolytic supplements are designed to eliminate “zombie ...

Drugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a "one-size-fits-all" remedy, Mayo Clinic researchers have found. Specifically, these drugs may only ...

Researchers from Juntendo University, Japan examine the molecular mechanisms underlying the senolytic or senescent cell removal effects of the the sodium glucose co-transporter 2 inhibitor and its ...

A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused on the effects of senolytic medications, Dasatinib and Quercetin (DQ), ...

MIAMI, March 5, 2025 /PRNewswire/ -- Immorta Bio Inc., a leader in longevity-focused biotechnologies, announced today acceptance of its poster presentation at the upcoming Society for Immunotherapy of ...

MIAMI, Sept. 24, 2025 /PRNewswire/ -- Immorta Bio, Inc., a scientific longevity company focused on "Treating Diseases of Aging and Treating Aging as Disease™," today announced the filing of a U.S.

Drugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a 'one-size-fits-all' remedy, Mayo Clinic researchers have found. Specifically, these drugs may only ...

A new research paper was published in Volume 17, Issue 8 of Aging-US on August 7, 2025, titled "Senescent cell heterogeneity and responses to senolytic treatment are related to cell cycle status ...